Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study - Abstract

PURPOSE OF THE RESEARCH:As the number of men living with prostate cancer is increasing worldwide, the requirement for follow up care also grows.

This study was undertaken to evaluate nurse-led, telephone follow up, for men with low to intermediate risk prostate cancer treated with radical radiotherapy when compared with medical follow up.

METHODS AND SAMPLE: A non-randomized, two-cohort, comparative study. 169 men diagnosed with prostate cancer were recruited from outpatient clinics at a tertiary cancer centre in Australia. 83 men were recruited to cohort 1 (control) (51 low to intermediate risk; 32 high risk) and 86 to cohort 2 (intervention) (51 low to intermediate risk; 35 high risk). High risk patients, regardless of cohort, received medical follow up. Low to intermediate risk patients in cohort 2 were triaged to nurse-led review for their six month review appointment. Nurse-led follow up consisted of six monthly telephone consultations and PSA testing.

MEASURES: Participants completed the Satisfaction with Consultation Scale, the Brief Distress Thermometer and the Expanded Prostate Cancer Index Composite.

KEY RESULTS: There was no statistically significant difference in patient satisfaction on any of the study measures between the nurse-led and standard medical follow up at six months following treatment completion. However, where there was a trend towards significance (p=0.051), it favoured the nurse-led follow up regimen.

CONCLUSIONS: Nurse-led telephone consultation provides an acceptable model of follow-up for men diagnosed with low to intermediate risk prostate cancer. Multi-centre randomised controlled trials are needed to support the efficacy of nurse-led, telephone follow up services.

Written by:
Leahy M, Krishnasamy M, Herschtal A, Bressel M, Dryden T, Tai KH, Foroudi F. Are you the author?
Division of Nursing, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Reference: Eur J Oncol Nurs. 2012 May 17. Epub ahead of print.
doi: 10.1016/j.ejon.2012.04.003

PubMed Abstract
PMID: 22608878 Prostate Cancer Section


email news signup